Drug
Dorzolamide-timolol
Dorzolamide-timolol is a pharmaceutical drug with 5 clinical trials. Historical success rate of 80.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
75%(3 trials)
Terminated
1(20%)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_2
2
40%
Ph phase_4
2
40%
Phase Distribution
0
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Terminated(1)
Detailed Status
Completed4
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
80.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (40.0%)
Phase 42 (40.0%)
N/A1 (20.0%)
Trials by Status
completed480%
terminated120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_4
Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety
NCT05857267
terminatedphase_4
How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure?
NCT06369077
completedphase_2
Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration
NCT03034772
completedphase_2
Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.
NCT02571972
completednot_applicable
Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma
NCT01175902
Clinical Trials (5)
Showing 5 of 5 trials
NCT05857267Phase 4
Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety
NCT06369077Phase 4
How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure?
NCT03034772Phase 2
Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration
NCT02571972Phase 2
Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.
NCT01175902Not Applicable
Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5